Performance characteristics of the COBAS AmpliScreen HIV-1 test, version 1.5, an assay designed for screening plasma mini-pools

Transfusion

Volumn 41, Issue 5, 2001, Pages 643-651

  Yang, Yanfeng ^a   Lamendola, Misty Hope ^a   Mendoza, Miguel ^a   Xu, Dick ^a   Nguyen, Minh ^a   Yeh, Sheria ^a   Wu, Yiqiao ^a   Ku, Joanne ^a   Rosenstraus, Maurice ^a,b   Sun, Rita ^a  

^a ROCHE MOLECULAR SYSTEMS   (United States)

^b HOFFMANN LA ROCHE INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; BILIRUBIN; HEMOGLOBIN; TRIACYLGLYCEROL; VIRUS RNA;

ACCURACY; ARTICLE; ASSAY; BLOOD SAMPLING; BLOOD TRANSFUSION; CLINICAL ARTICLE; CONTROLLED STUDY; EXTRACTION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; METHODOLOGY; PROTEIN DETERMINATION; SCREENING; SEROCONVERSION; VALIDATION PROCESS; VIRUS LOAD; VIRUS TRANSMISSION;

ACQUIRED IMMUNODEFICIENCY SYNDROME; HIV SEROPOSITIVITY; HIV-1; HUMANS; REPRODUCIBILITY OF RESULTS; RNA, VIRAL; SENSITIVITY AND SPECIFICITY;

EID: 17944375387     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1537-2995.2001.41050643.x     Document Type: Article

References (16)

1. Evolving applications of nucleic acid amplification assays for prevention of virus transmission by blood components and derivatives
2. Evaluation of a pooling method for routine anti-HCV screening of blood donors to lower the cost burden on blood banks in countries under development
3. Intersecting pools and their potential application in testing donated blood for viral genomes
4. Mini-pool screening by nucleic acid testing for hepatitis B virus, hepatitis C virus, and HIV: Preliminary results
5. Screening for HBV, HCV and HIV genomes in blood donations: Shortcomings of pooling revealed by a multicentre study simulating realtime testing
6. Redefining the HIV-infectious window period in the chimpanzee model: Evidence to suggest that viral nucleic acid testing can prevent bloodborne transmission
7. Feasibility and efficacy of routine PCR screening of blood donations for hepatitis C virus, hepatitis B virus, and HIV-1 in a blood-bank setting
8. Simultaneous extraction of hepatitis C virus (HCV), hepatitis B virus, and HIV-1 from plasma and detection of HCV RNA by a reverse transcriptase-polymerase chain reaction assay designed for screening pooled units of donated blood
9. PCR detection of human immunodeficiency virus type 1 proviral DNA sequences
10. High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR
11. Viral dynamics in primary HIV-1 infection
12. Quantification of HIV-1 RNA in plasma using NASBA during HIV-1 primary infection
13. Application of nucleic acid amplification techniques for blood donation screening
14. Nucleic acid amplification testing of blood donors for transfusion-transmitted infectious diseases: Report of the Interorganizational Task Force on Nucleic Acid Amplification Testing of Blood Donors
15. An internal control for routine diagnostic PCR: Design, properties and effect on clinical performance
16. Improved COBAS AMPLICOR™ viral assays as a basis for mini-pool screening of viruses in blood or plasma